<DOC>
	<DOCNO>NCT00786188</DOCNO>
	<brief_summary>This exploratory 8-week , multicenter , double-blind , randomize , placebo-controlled study Brisdelle ( paroxetine mesylate ) Capsules 7.5 mgin subject moderate severe postmenopausal vasomotor symptom ( VMS ) , define follow : - Moderate VMS : Sensation heat sweating , able continue activity - Severe VMS : Sensation heat sweating , cause cessation activity</brief_summary>
	<brief_title>Eight-Week Efficacy &amp; Safety Study Brisdelleâ„¢ ( Formerly Known Mesafem ) Treatment Vasomotor Symptoms Associated With Menopause</brief_title>
	<detailed_description>Eligible subject enter 1-week observation period follow 1-week run-in period . Following completion run-in period , eligible subject randomize receive either Brisdelle ( paroxetine mesylate ) Capsules 7.5 mg placebo 1:1 ratio . Study drug administer daily bedtime . Symptom assessment questionnaire administer baseline Day 28 Day 57 visit .</detailed_description>
	<mesh_term>Hot Flashes</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>1 . Female , &gt; 40 year age 2 . Reported 78 moderate severe hot flash per day ( average ) 5060 moderate severe hot flash per week least 30 day prior 3 . Spontaneous amenorrhea least 12 consecutive month 4 . Amenorrhea least 6 month meet biochemical criterion menopause 5 . Bilateral salpingooophorectomy &gt; 6 week without hysterectomy 1 . History hypersensitivity adverse reaction paroxetine mesylate 2 . Use investigational study medication within 30 day prior screen study 3 . Concurrent participation another clinical trial previous participation trial 4 . Family investigationalsite staff</criteria>
	<gender>Female</gender>
	<minimum_age>41 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Menopause</keyword>
	<keyword>Vasomotor Symptoms</keyword>
	<keyword>Hot flash</keyword>
	<keyword>Perimenopause</keyword>
	<keyword>Nonhormonal therapy</keyword>
	<keyword>Climacteric symptom</keyword>
	<keyword>Mesafem</keyword>
	<keyword>Low-Dose Mesylate salt Paroxetine ( LDMP )</keyword>
</DOC>